Tuberculosis Blood Test – A new and reliable method for the diagnosis of tuberculosis

Tuberculosis (TB) is a common infectious disease with a high morbidity and mortality. The absolute number of people suffering from TB each year is still increasing.

Caused by Mycobacterium tuberculosis, only about 10% of the people infected ever develop active TB. Since transmission occurs from people with the active disease these people need to be isolated and treated effectively to break the chain of transmission. The complex and not well understood immune response results in symptoms that are easily blamed on other infections. An easy, reliable and inexpensive test for the diagnosis of tuberculosis is still required. Scientists from the University of Bonn developed a new blood test for the molecular diagnosis of tuberculosis. This test is based on a blood-derived transcriptional signature that is suitable to distinguish patients with active TB from other individuals. With an “RNA-fingerprint”, an analysis of the different indicator RNAs – showing a decreased or increased expression rate as indication for TB – can be conducted.

Further Information: PDF

PROvendis GmbH
Phone: +49 (0)208/94105 10

Contact
Dipl.-Ing. Alfred Schillert

Media Contact

info@technologieallianz.de TechnologieAllianz e.V.

All latest news from the category: Technology Offerings

Back to home

Comments (0)

Write a comment

Newest articles

Recovering phosphorus from sewage sludge ash

Chemical and heat treatment of sewage sludge can recover phosphorus in a process that could help address the problem of diminishing supplies of phosphorus ores. Valuable supplies of phosphorus could…

Efficient, sustainable and cost-effective hybrid energy storage system for modern power grids

EU project HyFlow: Over three years of research, the consortium of the EU project HyFlow has successfully developed a highly efficient, sustainable, and cost-effective hybrid energy storage system (HESS) that…

After 25 years, researchers uncover genetic cause of rare neurological disease

Some families call it a trial of faith. Others just call it a curse. The progressive neurological disease known as spinocerebellar ataxia 4 (SCA4) is a rare condition, but its…

Partners & Sponsors